WebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.The institutional investor owned 961 shares of the biopharmaceutical … WebApr 10, 2024 · For additional information about Cytokinetics, visit www.cytokinetics.com and follow us on Twitter, LinkedIn, Facebook and YouTube. Forward-Looking Statements.
For Cytokinetics, FDA rejection of heart drug would help, not hinder
Web16 rows · Mar 27, 2024 · Cytokinetics is a late-stage biopharmaceutical company … WebWebsite: www.cytokinetics.com Headquarters: South San Francisco, CA Size: 201 to 500 Employees Founded: 1997 Type: Company - Public (CYTK) Industry: Biotech & Pharmaceuticals Revenue: Unknown / Non-Applicable Competitors: Ionis Pharmaceuticals, MyoKardia, PTC Therapeutics Create Comparison how many calories are in a bottle of cab
Analysts Have Conflicting Sentiments on These …
WebApr 10, 2024 · Cytokinetics currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. LGND - Free Report) , both sporting a Zacks Rank #1 at ... WebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have ... WebDec 13, 2024 · Cytokinetics continues its over 20-year history of pioneering innovation in muscle biology and related pharmacology focused to diseases of muscle dysfunction and conditions of muscle weakness. For additional information about Cytokinetics, visit www.cytokinetics.com and follow us on Twitter, LinkedIn, Facebook and YouTube. … high quality ghrp2 powder quotes